HomeCompareTBRIF vs MCD

TBRIF vs MCD: Dividend Comparison 2026

TBRIF yields 5263.16% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBRIF wins by $102432968530093.34M in total portfolio value
10 years
TBRIF
TBRIF
● Live price
5263.16%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102432968530093.42M
Annual income
$98,742,385,398,383,070,000.00
Full TBRIF calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — TBRIF vs MCD

📍 TBRIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBRIFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBRIF + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBRIF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBRIF
Annual income on $10K today (after 15% tax)
$447,368.42/yr
After 10yr DRIP, annual income (after tax)
$83,931,027,588,625,610,000.00/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, TBRIF beats the other by $83,931,027,588,625,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBRIF + MCD for your $10,000?

TBRIF: 50%MCD: 50%
100% MCD50/50100% TBRIF
Portfolio after 10yr
$51216484265046.75M
Annual income
$49,371,192,699,191,550,000.00/yr
Blended yield
96.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

TBRIF
No analyst data
Altman Z
-175.5
Piotroski
3/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBRIF buys
0
MCD buys
0
No recent congressional trades found for TBRIF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBRIFMCD
Forward yield5263.16%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$102432968530093.42M$78.5K
Annual income after 10y$98,742,385,398,383,070,000.00$26,227.70
Total dividends collected$102183681196311.97M$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: TBRIF vs MCD ($10,000, DRIP)

YearTBRIF PortfolioTBRIF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$537,016$526,315.79$10,815$334.85+$526.2KTBRIF
2$26,989,550$26,414,942.92$11,826$491.71+$26.98MTBRIF
3$1,269,600,822$1,240,722,003.32$13,123$730.06+$1269.59MTBRIF
4$55,904,391,573$54,545,918,693.73$14,853$1,100.07+$55904.38MTBRIF
5$2,304,512,049,686$2,244,694,350,703.24$17,257$1,690.61+$2304512.03MTBRIF
6$88,943,998,518,419$86,478,170,625,254.53$20,752$2,667.01+$88943998.50MTBRIF
7$3,214,493,329,356,589$3,119,323,250,941,881.00$26,103$4,354.83+$3214493329.33MTBRIF
8$108,798,712,659,598,690$105,359,204,797,187,140.00$34,794$7,437.78+$108798712659.56MTBRIF
9$3,449,143,113,747,977,000$3,332,728,491,202,206,700.00$49,926$13,461.60+$3449143113747.93MTBRIF
10$102,432,968,530,093,420,000$98,742,385,398,383,070,000.00$78,550$26,227.70+$102432968530093.34MTBRIF

TBRIF vs MCD: Complete Analysis 2026

TBRIFStock

Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.

Full TBRIF Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this TBRIF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBRIF vs SCHDTBRIF vs JEPITBRIF vs OTBRIF vs KOTBRIF vs MAINTBRIF vs YUMTBRIF vs QSRTBRIF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.